Sorafenib Tablet, Film Coated
Product Images NDC 43598-458

4 FDA label images from Dr.reddys Laboratories Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sorafenib (NDC 43598-458). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddys Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container (Container)

Container (Container)
Sorafenib Tablets, USP 200 mg film-coated tablets label showing the product strength and dosage form. The label indicates the package contains 120 tablets and is distributed by Dr. Reddy's Laboratories Inc. It includes storage instructions and an NDC code 43598-458-04, with additional patient information accessible via a QR code and website link.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A Kaplan-Meier survival curve comparing sorafenib (200 mg tablets) versus placebo. The chart depicts survival probability (%) over time in months from randomization up to 18 months. Sorafenib group (N=299) shows a median survival of 10.7 months, while placebo (N=303) has 7.9 months median survival. Hazard ratio (HR) is 0.69 with p=0.00058, indicating survival advantage. The number of patients at risk over time is shown below the x-axis for both groups.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
A Kaplan-Meier curve chart depicting the proportion of progression-free survival over time (in months) comparing sorafenib and placebo groups. The graph shows survival probabilities for 207 patients on sorafenib and 210 on placebo, with sorafenib group displaying higher progression-free survival throughout the study duration up to 27 months.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of sorafenib, showing its molecular framework with trifluoromethyl, chloro, ureido, phenoxy, pyridine, and methylurea functional groups, alongside the toluenesulfonic acid moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.